PC
OLMA icon

Pier Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Pier Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
220,699
+84,591
+62% +$1.13M 0.37% 96
2026
Q1 		$2.03M Sell
136,108
-3,993
-3% -$88.9K 0.33% 94
2025
Q4 		$3.5M Sell
140,101
-384,148
-73% -$6.84M 0.56% 86
2025
Q3 		$5.13M Sell
524,249
-246,823
-32% -$1.48M 0.8% 63
2025
Q2 		$3.28M Sell
771,072
-46,889
-6% -$209K 0.5% 87
2025
Q1 		$3.08M Buy
817,961
+545,589
+200% +$2.74M 0.52% 85
2024
Q4 		$1.59M Buy
+272,372
New +$2.72M 0.23% 87

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Pier Capital's OLMA Position: Q2 2026 in Review

Pier Capital increased its Olema Pharmaceuticals (OLMA) stake by 62% in Q2 2026, buying an estimated $1.13M and bringing the position to 220,699 shares worth $2.76M. The position accounts for 0.37% of the portfolio, ranked #96.

Pier Capital first reported a position in OLMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.13M in Q3 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Pier Capital held 220,699 shares of Olema Pharmaceuticals worth $2.76M as of Q2 2026.
  • Pier Capital bought 84,591 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.13M.
  • Olema Pharmaceuticals made up 0.37% of Pier Capital's portfolio in Q2 2026, its #96 holding.
  • Pier Capital first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Pier Capital's Olema Pharmaceuticals position peaked at $5.13M in Q3 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.